Literature DB >> 31081096

MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.

Z-M Liu1, Z-Y Wu, W-H Li, L-Q Wang, J-N Wan, Y Zhong.   

Abstract

OBJECTIVE: MicroRNAs (miRNAs) have been identified to play an important regulatory role in various biological behaviors of papillary thyroid carcinoma (PTC). However, the specific role and function of miR-96-5p in PTC remain unclear. Therefore, the aim of this study is to detect the expression of miR-96-5p in PTC, and to explore its exact function. PATIENTS AND METHODS: The relative expression level of miR-96-5p in PTC tissues and cell lines was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). MiR-96-5p mimics or inhibitors were then constructed and transfected into cells to upregulate or downregulate miR-96-5p expression. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay and colony formation assay were employed to evaluate the proliferation of PTC cells. Meanwhile, transwell assay was employed to detect the invasion and metastasis of PTC cells. In addition, the underlying mechanism of miR-96-5p was identified by Luciferase reporter gene assay and Western blot analysis.
RESULTS: The expression of miR-96-5p in PTC tissues and PTC-derived cell lines was significantly higher than that of normal controls. The overexpression of miR-96-5p remarkably promoted the proliferation, invasion and migration of PTC cells. However, knockdown of miR-96-5p significantly decreased cell growth and metastasis. CCDC67 was verified as a target gene of miR-96-5p in PTC. Further experiments demonstrated that the restoration of CCDC67 could significantly reduce the carcinogenic function of miR-96-5p.
CONCLUSIONS: MiR-96-5p was remarkably upregulated in PTC tumor tissues and cells. In addition, it promoted cell growth, invasion, and migration via repressing CCDC67 expression.

Entities:  

Year:  2019        PMID: 31081096     DOI: 10.26355/eurrev_201904_17706

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  13 in total

1.  miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1.

Authors:  Silei Chen; Yajuan Luo; Liangyi Cui; Qing Yang
Journal:  Cell Cycle       Date:  2020-06-17       Impact factor: 4.534

Review 2.  MicroRNA-96: A therapeutic and diagnostic tumor marker.

Authors:  Hamid Reza Rahimi; Majid Mojarrad; Meysam Moghbeli
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

3.  MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway.

Authors:  Qian Liang; Huan Zhang
Journal:  Cancer Biol Ther       Date:  2020-12-07       Impact factor: 4.742

4.  MicroRNA-96-5p represses breast cancer proliferation and invasion through Wnt/β-catenin signaling via targeting CTNND1.

Authors:  Xiao-Hui Gao; Ya-Li Zhang; Zhi-Ye Zhang; Shuang-Shuang Guo; Xiao-Bing Chen; Yan-Zhen Guo
Journal:  Sci Rep       Date:  2020-01-08       Impact factor: 4.379

5.  MicroRNA‑15b‑5p exerts its tumor repressive role via targeting GDI2: A novel insight into the pathogenesis of thyroid carcinoma.

Authors:  Jidong Zou; Jiantong Qian; Haiyan Fu; Fawen Yin; Wanjun Zhao; Liang Xu
Journal:  Mol Med Rep       Date:  2020-07-15       Impact factor: 2.952

6.  lncRNA HOTAIRM1 regulates cell proliferation and the metastasis of thyroid cancer by targeting Wnt10b.

Authors:  Chenyao Li; Xinxin Chen; Tao Liu; Guang Chen
Journal:  Oncol Rep       Date:  2020-12-31       Impact factor: 3.906

7.  Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis.

Authors:  Ping Zhou; Tongdao Xu; Hao Hu; Fei Hua
Journal:  Int J Endocrinol       Date:  2021-10-26       Impact factor: 3.257

8.  Diagnostic and Prognostic Value of MicroRNAs in Metastasis and Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke Qiu; Yao Song; Yufang Rao; Qiurui Liu; Danni Cheng; Wendu Pang; Jianjun Ren; Yu Zhao
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

9.  Epigenetic Silencing of SOX15 Is Controlled by miRNAs rather than Methylation in Papillary Thyroid Cancer.

Authors:  Ahmet Ozaydin; Aysegul Soysal; Betul Seyhan; Soykan Arikan; Nejat Dalay; Nur Buyru
Journal:  Dis Markers       Date:  2021-09-24       Impact factor: 3.434

10.  Prognostic Value and Significant Pathway Exploration Associated with TOP2A Involved in Papillary Thyroid Cancer.

Authors:  Mou-Chun Gong; Wei-Qing Chen; Zhao-Qing Jin; Jia Lyu; Li-Hao Meng; Hai-Yan Wu; Fei-Hua Chen
Journal:  Int J Gen Med       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.